Trials / Terminated
TerminatedNCT01032694
Non-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Mild To Moderate Community Acquired Pneumonia
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To compare compliance between patients with CAP treated with Azithromycin SR 2.0 g single dose orally and those treated with Amoxiclav - 1000 mg twice daily 10 days for the empiric treatment of CAP in outpatient clinic practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin SR | Azithromycin SR, 2.0 g PO x 1 dose for treatment period |
| DRUG | Amoxiclav | Amoxiclav 1000 x twice daily, 10 days duration |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2009-12-15
- Last updated
- 2011-12-21
- Results posted
- 2011-12-21
Source: ClinicalTrials.gov record NCT01032694. Inclusion in this directory is not an endorsement.